VRTX 13F Hedge Fund and Asset Management Owners

Data as of 2020-10-17
Market Cap	56.803 Billion	Shares Outstanding	260.467 Million	Avg 30-day Volume	1.922 Million
P/E Ratio	27.2	Dividend Yield		EPS	7.92
Price/Sales	12.756	Price cash flow ratio	21.4	Price free cash flow ratio	41.9
Book Value	28.87	Price to Tangible Book	9.17	Alpha	0.01
Short Interest Ratio		% Short Interest to Float		R-squared	0.135654
BETA	0.788777	52-week High/Low	306.08 / 174.82	Stddev	0.091974

Q2 2020	All 13F Filers	Prior	Change	Hedge Funds ¹	Prior	Change
In top 10:	24	29	-17.24%	7 (0.46%)	11 (0.7%)	-36.36%
Funds Holding:	927	833	11.28%	192 (12.52%)	182 (11.64%)	5.49%
13F shares:	240.351 Million	242.257 Million	-0.79%	50.343 Million	53.924 Million	-6.64%
% Ownership	92.2767	93.4385	-1.24%	19.3281	20.7986	-7.07%
New Positions:	165	132	25.0%	35	31	12.9%
Increased Positions	393	320	22.81%	80	64	25.0%
Closed Positions	60	86	-30.23%	20	26	-23.08%
Reduced Positions	263	274	-4.01%	62	74	-16.22%
Total Calls	1.116 Million	1.242 Million	-10.17%	419.4 Thousand	365.9 Thousand	14.62%
Total Puts	1.113 Million	1.068 Million	4.25%	441.9 Thousand	335.4 Thousand	31.75%
PUT/CALL Ratio	1.0	0.86	16.28%	1.05	0.92	14.13%
¹ hedge funds and active managers as identified by whalewisdom.com through public filings.

Funds Holding VRTX (via 13F filings)

Quarter to view: Refresh Download CSV Download Excel (.xlsx) Download TSV

Market Value:

Ranking:

% of portfolio

*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VRTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

10.5 Thousand total shares from 7 transactions

Exercise Derivative Conversion (M)

8.7 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name	Type	Last Reported Shares Held	Last Reported Date	Filings in past year
SACHS BRUCE I	Director	0	2020-10-15	7
MCKENZIE DIANA	Director	0	2020-10-15	4
BHATIA SANGEETA N.	Director	3,908	2020-10-05	3
MCGLYNN MARGARET G	Director	877	2020-08-25	4
SILVA PAUL M SVP & CONTROLLER	Officer	15,101	2020-08-06	17
ALTSHULER DAVID EVP, GLOBAL RESEARCH AND CSO	Officer	28,902	2020-08-06	16
PARINI MICHAEL EVP, CHIEF ADM, LEG & BD OFF	Officer	26,838	2020-08-06	19
KEWALRAMANI RESHMA CEO & PRESIDENT	Officer Director	26,626	2020-08-06	11
SACHDEV AMIT EVP, CHIEF PATIENT OFFICER	Officer	49,987	2020-08-03	19
ARBUCKLE STUART A EVP, CHIEF COMMERCIAL OFFICER	Officer	35,319	2020-08-03	12
WAGNER CHARLES F JR EVP & CHIEF FINANCIAL OFFICER	Officer	16,126	2020-07-10	4
LEIDEN JEFFREY M EXECUTIVE CHAIRMAN	Officer Director	2,701	2020-06-30	14
KEARNEY TERRENCE C	Director	0	2020-06-01	2
LEE YUCHUN	Director	0	2020-06-01	10
YOUNG WILLIAM D	Director	0	2020-06-01	3
GARBER ALAN M	Director	5,890	2020-06-01	1
CARNEY LLOYD	Director	3,559	2020-06-01	1
BOZIC CARMEN EVP AND CMO	Officer	13,991	2020-05-29	3
TATSIS OURANIA EVP, CHIEF REGULATORY OFFICER	Officer	12,738	2020-05-15	8
ULLIAN ELAINE	Director	0	2019-06-01	0
GRANEY THOMAS CHIEF FINANCIAL OFFICER	Officer	12,430	2018-10-01	0
SMITH IAN F EVP, COO	Officer	52,005	2018-06-29	0
CHODAKEWITZ JEFFREY EVP	Officer	No longer subject to file	2018-04-01	0
BOGER JOSHUA S	Director	No longer subject to file	2017-06-08	0
RILEY WAYNE JOSEPH	Director	0	2015-06-01	0
CONNOLLY THOMAS SVP, HUMAN RESOURCES	Officer	34,525	2014-12-12	0
HORTON KENNETH L EVP & CHIEF LEGAL OFFICER	Officer	72,419	2014-11-17	0
PACE MEGAN E SVP, CORP. COMMUNICATIONS	Officer	43,350	2014-11-17	0
MUELLER PETER EVP, GLOBAL R&D, CSO	Officer	169,088	2014-06-16	0
STAMOULIS CHRISTIANA SVP, CORP STRATEGY & BUS DEVLP	Officer	0	2013-07-30	0
KELLY LISA SVP, HUMAN RESOURCES	Officer	27,347	2013-02-05	0
EMMENS MATTHEW	Director	0	2012-06-01	0
WYSENSKI NANCY EVP, CHIEF COMMERCIAL OFFICER	Officer	32,232	2012-05-14	0
WINGER DENNIS L	Director	6,500	2012-03-09	0
HOWTON DAVID T SVP & CHIEF LEGAL OFFICER	Officer	19,703	2012-02-02	0
BOGER KENNETH S SVP & CHIEF LEGAL OFFICER	Officer	292,187	2011-09-13	0
CORDES EUGENE	Director	12,000	2011-03-17	0
SANDERS CHARLES A	Director	0	2010-06-01	0
COLLINSON STUART J	Director	0	2010-06-01	0
BRIMBLECOMBE ROGER W	Director	0	2010-03-15	0
GRAVES KURT EVP, CHIEF COMMERCIAL OFFICER	Officer	60,485	2009-10-19	0
GARRISON RICHARD C SVP AND CATALYST	Officer	38,782	2009-05-18	0
LEWIS-HALL FREDA C EVP, MEDICINES DEVELOPMENT	Officer	53,334	2009-03-19	0
BRANDT ERIC	Director	0	2009-01-29	0
ALAM JOHN J EVP, MED. DEV. GROUP & CMO	Officer	141,932	2008-10-01	0
POWER JOHANNA MESSINA VP & CONTROLLER	Officer	0	2008-07-24	0

Insider Transactions Last 60 Days

Reporting Owners	Filing Date	Trans Date	Trans Code	Shares	Share Price	Acquired Disposed	Shares Owned after	D/I	10b5	Perf 1d*	Perf 5d*	Perf 1m*	Max Gain	Max Gain Days	Max Loss	Max Loss Days
MCKENZIE DIANA - Director	2020-10-19 16:13:59 -0400	2020-10-15	A	112	$222.81	a	138	direct
SACHS BRUCE I - Director	2020-10-19 16:15:16 -0400	2020-10-15	A	196	$222.81	a	12,629	direct
BHATIA SANGEETA N. - Director	2020-10-07 16:11:31 -0400	2020-10-05	S	2,212	$268.61	d	3,908	direct	yes	0.5288	-19.8302		2.8153	4	-19.8302	6
BHATIA SANGEETA N. - Director	2020-10-07 16:11:31 -0400	2020-10-05	S	1,787	$265.82	d	10,860	direct	yes	0.5288	-19.8302		2.8153	4	-19.8302	6
BHATIA SANGEETA N. - Director	2020-10-07 16:11:31 -0400	2020-10-05	S	291	$262.66	d	14,133	direct	yes	0.5288	-19.8302		2.8153	4	-19.8302	6
BHATIA SANGEETA N. - Director	2020-10-07 16:11:31 -0400	2020-10-05	S	2,670	$267.92	d	6,120	direct	yes	0.5288	-19.8302		2.8153	4	-19.8302	6
BHATIA SANGEETA N. - Director	2020-10-07 16:11:31 -0400	2020-10-05	S	892	$264.60	d	12,647	direct	yes	0.5288	-19.8302		2.8153	4	-19.8302	6
BHATIA SANGEETA N. - Director	2020-10-07 16:11:31 -0400	2020-10-05	M	8,729	$126.68	a	14,424	direct		0.5288	-19.8302		2.8153	4	-19.8302	6
BHATIA SANGEETA N. - Director	2020-10-07 16:11:31 -0400	2020-10-05	M	8,729		d	0	direct
BHATIA SANGEETA N. - Director	2020-10-07 16:11:31 -0400	2020-10-05	S	2,070	$266.66	d	8,790	direct	yes	0.5288	-19.8302		2.8153	4	-19.8302	6
BHATIA SANGEETA N. - Director	2020-10-07 16:11:31 -0400	2020-10-05	S	594	$263.54	d	13,539	direct	yes	0.5288	-19.8302		2.8153	4	-19.8302	6
MCGLYNN MARGARET G - Director	2020-08-26 16:14:23 -0400	2020-08-25	G	3,707		d	877	direct		-1.5966	-2.5224	-1.6002	2.7521	5	-6.8127	10

* -

Transaction Code Definitions
Code	Definition
A	Grant, award or other acquisition pursuant to Rule 16b-3(d)
C	Conversion of derivative security
D	Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E	Expiration of short derivative position
F	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G	Bona fide gift
H	Expiration (or cancellation) of long derivative position with value received
I	Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J	Other acquisition or disposition
L	Small acquisition under Rule 16a-6
M	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O	Exercise of out-of-the-money derivative security
P	Open market or private purchase of non-derivative or derivative security
S	Open market or private sale of non-derivative or derivative security
U	Disposition pursuant to a tender of shares in a change of control transaction
W	Acquisition or disposition by will or the laws of descent and distribution
X	Exercise of in-the-money or at-the-money derivative security
Z	Deposit into or withdrawal from voting trust

Vertex Pharmaceuticals, Inc. Chart by YCharts
Yahoo! Finance	finviz
SEC Web Site	SEC DEF 14A Filings

Vertex Pharmaceuticals, Inc. (VRTX)

WhaleWisdom Alpha

Our Other Reporting & Analysis